The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during ...

Manchester City were beaten at Newcastle at the weekend but have won three out of four undefeated Champions League games this ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

The Chinese e-commerce leader said its Qwen artificial-intelligence app drew more than 10 million downloads i ...

German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a ...

The fifth round of matches in the 2025-26 Champions League group phase will see Manchester City welcome Bayer Leverkusen to ...

Find out everything you need to know ahead of City's Champions League encounter with Bayer Leverkusen.WHEN AND WHEREWe host ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Bayer shares surge after its asundexian stroke drug shows positive Phase III results, offering a key boost to its pipeline ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes ...

Investing.com -- Bayer’s (ETR:BAYGN) experimental stroke drug could generate €3 billion in annual sales after successful trial results that Goldman Sachs analyst James Quigley called "transformational ...

Bayer’s net loss narrowed in the third quarter but additional litigation provisions weighed on its crop-science business.